Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 4.400
-0.020 (-0.45%)
Aug 31, 2026, 3:07 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €123.76 million as of August 31, 2026. Its market cap has decreased by -32.00% in one year.
Market Cap
123.76M
Enterprise Value
111.60M
Revenue
7.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.40
ChartMarket Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 123.76M, a decrease of -49.42%. That is a compound annual growth rate of -10.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 123.76M | -35.38% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 55.98B |
| UCB SA | 41.28B |
| Financière de Tubize | 8.30B |
| Onward Medical | 171.74M |
| European Medical Solutions | 14.81M |
| Celyad Oncology | 11.68M |
| BioSenic | 1.31M |
| Oxurion NV | 230.60K |